"Dynavax is excited for the opportunity to expand our partnership with Clover into an important commercial supply agreement to provide significant amounts of CpG 1018 for combatting the ongoing pandemic," Dynavax CEO Ryan Spencer said. "We are proud to support the ongoing development and the potential near-term commercialization of SCB-2019 (CpG 1018/Alum)."